Eastern Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Sell
69,229
-262,227
-79% -$14.2M 0.05% 137
2026
Q1
$20.8M Buy
331,456
+50,829
+18% +$4.07M 0.36% 70
2025
Q4
$26.8M Sell
280,627
-12,551
-4% -$1.23M 0.46% 53
2025
Q3
$28.6M Buy
293,178
+24,600
+9% +$2.55M 0.51% 50
2025
Q2
$28.8M Buy
268,578
+59,385
+28% +$6.01M 0.55% 48
2025
Q1
$21.1M Sell
209,193
-95,688
-31% -$9.64M 0.41% 56
2024
Q4
$27.2M Sell
304,881
-3,327
-1% -$293K 0.51% 57
2024
Q3
$25.8M Buy
308,208
+11,848
+4% +$934K 0.46% 66
2024
Q2
$22.8M Buy
296,360
+56,457
+24% +$4.13M 0.92% 39
2024
Q1
$16.4M Buy
239,903
+4,519
+2% +$291K 0.68% 54
2023
Q4
$13.6M Buy
235,384
+6,256
+3% +$334K 0.62% 63
2023
Q3
$12.1M Buy
+229,128
New +$12M 0.6% 65

Other funds holding BSX

Eastern Bank's BSX Position: Q2 2026 in Review

Eastern Bank reduced its Boston Scientific (BSX) stake by 79% in Q2 2026, selling an estimated $14.2M and leaving 69,229 shares worth $2.95M. The position accounts for 0.05% of the portfolio, ranked #137.

Eastern Bank first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $28.8M in Q2 2025. 209 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Eastern Bank held 69,229 shares of Boston Scientific worth $2.95M as of Q2 2026.
  • Eastern Bank sold 262,227 Boston Scientific shares in Q2 2026, an estimated $14.2M.
  • Boston Scientific made up 0.05% of Eastern Bank's portfolio in Q2 2026, its #137 holding.
  • Eastern Bank first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Eastern Bank's Boston Scientific position peaked at $28.8M in Q2 2025.
  • 209 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.